Table 1.
Anthropometrics, General Characteristics, and Two-Week CGM Metrics of the Study Participants in the Whole Cohort and According to the Type of Hybrid Closed-Loop System (Mean ± SD).
| Overall (n = 120) |
670G (n = 40) |
780G (n = 49) |
C-IQ (n = 31) |
|
|---|---|---|---|---|
| Gender (M/F) | 61/59 | 21/19 | 24/25 | 16/15 |
| Age (years) | 40.6 ± 12.6 | 42.3 ± 12.2 | 40.7 ± 12.3 | 38.2 ± 13.7 |
| Body weight (kg) | 72.5 ± 14.5 | 72.8 ± 11.6 | 72.9 ± 15.5 | 71.6 ± 15.6 |
| Body mass index (kg/m2) | 25.8 ± 3.8 | 25.6 ± 3.2 | 26.3 ± 4.2 | 25.2 ± 3.6 |
| Duration of diabetes (years) | 22.9 ± 12.2 | 21.5 ± 13.6 | 24.5 ± 11.3 | 22.1 ± 11.9 |
| HbA1c (%) HbA1c (mmol/mol) |
7.2 ± 0.9 54.9 ± 10.6 |
7.3 ± 0.7 54.2 ± 12.7 |
7.4 ± 0.9 57.7 ± 9.7 |
6.9 ± 0.8
a
51.5 ± 9.1 a |
| TIR 70-180 mg/dL (%) | 71.9 ± 11.1 | 72.2 ± 9.6 | 74.0 ± 8.2 | 68.1 ± 15.4 |
| TAR 180-250 mg/dL (%) | 20.0 ± 6.7 | 20.7 ± 6.5 | 19.2 ± 6.1 | 20.6 ± 7.7 |
| TAR >250 mg/dL (%) | 5.9 ± 6.1 | 5.2 ± 4.0 | 4.3 ± 3.5 | 9.4 ± 9.4 b |
| TBR 54-70 mg/dL (%) | 1.7 ± 1.8 | 1.6 ± 1.4 | 1.9 ± 2.3 | 1.4 ± 1.2 |
| TBR <54 mg/dL (%) | 0.4 ± 0.9 | 0.3 ± 0.5 | 0.5 ± 1.3 | 0.4 ± 0.6 |
| GMI (%) | 7.0 ± 0.4 | 6.9 ± 0.3 | 6.9 ± 0.3 | 7.1 ± 0.6 |
| CV (%) | 33.1 ± 4.3 | 32.6 ± 3.5 | 32.8 ± 4.6 | 34.2 ± 4.5 |
Abbreviations: CGM, continuous glucose monitoring; TIR, time-in-range; TAR, time-above-range; TBR, time-below-range; GMI, glucose management indicator; CV, coefficient of variation.
a
P < .05 vs 780G; bP < .05 vs 670G and 780G, by post hoc ANOVA.